The Electrospinning Company, a leading innovator in nanofibrous biomaterials for medical devices, has announced a strategic partnership with Avem Market Solutions to bring its advanced products to a broader range of medical device customers. This collaboration will combine Electrospinning’s cutting-edge biomaterials with Avem’s deep industry expertise to accelerate the development and commercialisation of differentiated medical technologies.
The Electrospinning Company specializes in the design, development, and manufacture of advanced nanofibrous biomaterials and coatings for implantable medical devices. The company’s product portfolio includes four core technology platforms: Mimetix® resorbable membranes, Kalyptix® non-resorbable membranes, Symatix® bio-synthetic membranes, and Caladrix®, a coating technology for medical textiles applied to both metal and non-metal 3D structures. In addition to offering a comprehensive range of proprietary materials, the company provides tailored contract development and manufacturing services to meet specific customer needs.
Avem Market Solutions is well-regarded across Europe, the USA, and the Middle East for its expertise in the medical OEM sector. With a strong track record of facilitating product development and commercial success, Avem will represent Electrospinning’s innovative membranes and coatings to medical device manufacturers focused on improving patient outcomes. By leveraging Avem’s technical sales experience and deep knowledge of medical materials, manufacturing processes, and global market dynamics, the partnership will create synergies that drive solutions for R&D and commercial teams developing next-generation medical devices.
Eoghan Mulrooney has been appointed as the main point of contact for the Electrospinning account. He will work closely with the teams from both Electrospinning and Avem to manage new projects and business development inquiries.
Avem CEO (second from right) and Business Development Manager Eoghan (second from left) at the Electrospinning Company office, as Eoghan steps into his new role representing Electrospinning
Ann Kramer, CEO of Electrospinning, commented:
“We are thrilled to partner with Avem, a team with the expertise and network to introduce our advanced biomaterials to a wider customer base. This partnership will enable us to deliver our innovative solutions to companies developing differentiated medical devices that are poised to improve patient outcomes globally.”
Lorraine Eagleton, CEO of Avem Market Solutions, added:
“Collaborating with Electrospinning aligns perfectly with our mission to connect the most innovative technologies with customers in need of high-performance solutions. The Electrospinning Company’s technologies bring many advantages to the implantable device market and truly compliments the products and services offered by our current “Suppliers to Medtec” portfolio. We are excited to help bring Electrospinning’s nanofibrous biomaterials to market and contribute to the development of products that will have a positive impact on patient care.”
Contact:
Electrospinning: Ann Kramer, CEO info@electrospinning.co.uk
Avem: Lorraine Eagleton, CEO leagleton@avemmarketsolutions.com
